메뉴 건너뛰기
.. 내서재 .. 알림
소속 기관/학교 인증
인증하면 논문, 학술자료 등을  무료로 열람할 수 있어요.
한국대학교, 누리자동차, 시립도서관 등 나의 기관을 확인해보세요
(국내 대학 90% 이상 구독 중)
로그인 회원가입 고객센터 ENG
주제분류

추천
검색

논문 기본 정보

자료유형
학술저널
저자정보
Song Joon Young (Division of Infectious Diseases Department of Internal Medicine Korea University Guro Hospital Kore) Cheong Hee Jin (Division of Infectious Diseases Department of Internal Medicine Korea University Guro Hospital Kore) Kim Sung Ran (Department of Hospital Infection Control Korea University Guro Hospital Seoul Korea.) Lee Sung Eun (Department of Hospital Infection Control Korea University Anam Hospital Seoul Korea.) Kim Su Hyun (Department of Hospital Infection Control Korea University Ansan Hospital Ansan Korea.) Noh Ji Yun (Division of Infectious Diseases Department of Internal Medicine Korea University Guro Hospital Kore) Yoon Young Kyung (Department of Hospital Infection Control Korea University Anam Hospital Seoul Korea.Division of Inf) Choi Won Suk (Department of Hospital Infection Control Korea University Ansan Hospital Ansan Korea.Division of In) Park Dae Won (Department of Hospital Infection Control Korea University Ansan Hospital Ansan Korea.Division of In) Sohn Jang Wook (Department of Hospital Infection Control Korea University Anam Hospital Seoul Korea.Division of Inf) Kim Woo Joo (Division of Infectious Diseases Department of Internal Medicine Korea University Guro Hospital Kore) Kim Min Ja (Department of Hospital Infection Control Korea University Anam Hospital Seoul Korea.Division of Inf)
저널정보
대한의학회 Journal of Korean Medical Science Journal of Korean Medical Science Vol.36 No.15
발행연도
2021.1
수록면
1 - 4 (4page)

이용수

표지
📌
연구주제
📖
연구배경
🔬
연구방법
🏆
연구결과
AI에게 요청하기
추천
검색

초록· 키워드

오류제보하기
Hospital-based surveillance for adverse events was conducted on healthcare workers after they received the first dose of coronavirus disease 2019 (COVID-19) vaccine. Among the two new platform vaccines (messenger RNA- and adenoviral vector-based vaccines), the rates of systemic adverse events were significantly higher among adenovirus-vectored vaccine recipients. Fatigue (87.6% vs. 53.8%), myalgia (80.8% vs. 50.0%), headache (72.0% vs. 28.8%), and fever (≥ 38.0°C, 38.7% vs. 0%) were the most common adverse events among adenovirus-vectored vaccine recipients, but most symptoms resolved within 2 days. Both types of COVID-19 vaccines were generally safe, and serious adverse events rarely occurred.

목차

등록된 정보가 없습니다.

참고문헌 (6)

참고문헌 신청

이 논문의 저자 정보

최근 본 자료

전체보기

댓글(0)

0